Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on April 22, 2025
Oncologists invited to RSVP for the 13th Annual Giants of Cancer Care Awards Ceremony honoring oncology leaders
GlobeNewswire
·
April 22, 2025
CRANBURY, N.J., April 22, 2025 (GLOBE NEWSWIRE) -- OncLive invites physicians and oncology professionals to attend the 13th Annual Giants of Cancer Care® Awards Ceremony, an evening dedicated to celebrating visionary achievements in oncology. The …
Digital Dental Lab Dandy Appoints Head of Engineering to Lead Next Wave of AI-Powered Design and Manufacturing
GlobeNewswire
·
April 22, 2025
NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Dandy, the leading fully digital dental lab, has named Cong Yu its new Head of Engineering. Yu brings decades of experience: most recently, he served as VP of Engineering at Celonis, where he built and led the …
Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from April 11, 2025…
GlobeNewswire
·
April 22, 2025
PALO ALTO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the …
Trethera To Participate in Panel Discussion and Research Poster Competition At Los Angeles Bioscience Ecosystem Summit 2025
GlobeNewswire
·
April 22, 2025
LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announces a forthcoming panel discussion and poster …
Nerve Freedom Reviews [Investigated Complaints] Nerve Alive Best Neuropathy Supplement for Nerve Pain Relief Naturally
GlobeNewswire
·
April 22, 2025
LAKELAND, Fla., April 22, 2025 (GLOBE NEWSWIRE) -- Introduction to Nerve Freedom! Nerve Pain often referred to as neuropathy — is one of the most frustrating and debilitating conditions a person can endure. Whether it manifests as a tingling sensation, …
Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey
GlobeNewswire
·
April 22, 2025
In a survey representative of the general U.S. adult population, 1.26 percent of respondents – equivalent to about 3 million people – reported having received a medical diagnosis of babesiosis during their life-time; CDC data imply only about 73,000 people …
科兴控股生物技术有限公司管理层关于审计师辞职的声明
GlobeNewswire
·
April 22, 2025
北京, April 22, 2025 (GLOBE NEWSWIRE) -- 致科兴控股生物技术有限公司全体股东及各利益相关方： 科兴控股生物技术有限公司（纳斯达克股票代码：SVA，以下简称 “公司”）的管理层近日收到公司外部审计师的通知，审计师已决定辞去公司2024 财年年终审计师职务。 根据审计师的辞职信，审计师的辞职决定源于公司现任董事会于2025年4月1 …
Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting
GlobeNewswire
·
April 22, 2025
IRVINE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) will present four distinct data sets highlighting the global prevalence and real-world patient burden of Demodex blepharitis, as well as the impact of XDEMVY® ( …
AP Biosciences Doses First Patient in Phase 1/2 Clinical Trials of AP402 for HER2+ Cancer Patients
GlobeNewswire
·
April 22, 2025
TAIPEI, Taiwan, April 22, 2025 (GLOBE NEWSWIRE) -- AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through development of innovative bispecific antibodies, today announced that it has dosed the first …
Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call
GlobeNewswire
·
April 22, 2025
MALVERN, Pa., April 22, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, …
US Healthcare Analytics Market worth US$47.40 billion by 2029 with 24.5% CAGR | MarketsandMarkets™.
GlobeNewswire
·
April 22, 2025
Delray Beach, FL, April 22, 2025 (GLOBE NEWSWIRE) -- The global US Healthcare Analytics Market, valued at US$15.84 billion in 2024, is forecasted to grow at a robust CAGR of 24.5%, reaching US$47.40 billion by 2029. The major factors driving the market …
Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream
GlobeNewswire
·
April 22, 2025
A Scientific Breakthrough in Skin Renewal: A Clinically Proven Dual-Action, Slow-Release, Overnight Skin Renewal Cream for a Resurfaced, Smoother, and More Even-Looking Complexion NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Obagi Medical ("Obagi"), the …
Ernexa Therapeutics Announces New Data to be Presented at AACR Annual Meeting 2025
GlobeNewswire
·
April 22, 2025
CAMBRIDGE, Mass., April 22, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that new data will be presented at the American …
Day One to Report First Quarter 2025 Financial Results Tuesday, May 6, 2025
GlobeNewswire
·
April 22, 2025
BRISBANE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life- …
Rakovina Therapeutics Congratulates Scientific Advisor Dr. Artem Cherkasov on Global Recognition for Breakthrough AI Innovation in Drug Discovery
GlobeNewswire
·
April 22, 2025
VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to …
Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction
GlobeNewswire
·
April 22, 2025
Forms Special Committee of the Board to Lead Evaluation of Viable Options for Maximizing Shareholder Value Engages Independent Financial and Legal Advisors to Support Thorough Process Remains Committed to Maintaining Focus on Cost Containment, Cash …
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System
GlobeNewswire
·
April 22, 2025
Company expands Intelligent Fingerprinting Drug Screening System multilingual capabilities to meet growing demand across Latin American Spanish-speaking markets Latin American drug screening market projected to reach USD 1.1 billion by 2030 Expansion is …
The Best Natural Testosterone Booster Supplements For Men:~ Honest Customer Reviews 2025
GlobeNewswire
·
April 22, 2025
NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Low testosterone levels can cause many problems in men, such as less muscle, less energy, less libido and low mood. You may want to find a solution, but you don’t know which products are good and which are bad. …
BlueGenes Partners with Level Care to Revolutionize Medication Management for Union Members
GlobeNewswire
·
April 22, 2025
SCOTTSDALE, Ariz., April 22, 2025 (GLOBE NEWSWIRE) -- BlueGenes, a pioneering technology company specializing in permission medicine, today announced a strategic partnership with Level Care, the healthcare division of the carpenters union. This …
Theranica Announces Coverage Policy from the Second Largest U.S. Health Insurer for Its Nerivio® REN Wearable Migraine Treatment, Reaching Access for 80 Million Americans
GlobeNewswire
·
April 22, 2025
BRIDGEWATER, N.J. and NETANYA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- Theranica, a prescribed neuromodulation therapeutics company, today announced that that its FDA-cleared, non-drug, prescribed migraine treatment, the Nerivio® REN wearable, is now …